Anebulo Pharmaceuticals's total assets for Q2 2024 were $7.50M, a decrease of -17.10% from the previous quarter. ANEB total liabilities were $1.01M for the fiscal quarter, a 41.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.